Steven Quayle,Simon Stewart Jones,Teru Hideshima,Kenneth C. Anderson
申请号：
US16463140
公开号：
US20190282573A1
申请日:
2017.11.21
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present disclosure relates to a pharmaceutical combination comprising (a) a histone deacetylase 6 inhibitor and (b) a programmed death ligand 1 (PD-L1) inhibitor, including combined preparations and pharmaceutical compositions thereof； uses of such combination in the treatment or prevention of cancer； and methods of treating or preventing cancer in a subject comprising administering a therapeutically effective amount of such combination.
